- Investing Ideas
- Hong Kong Healthcare Undervalued based on future growth
Hong Kong Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
Sinopharm Group
Market Cap: HK$49.2b
Engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China.
1099
HK$15.98
7D
-2.4%
1Y
-14.3%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$5.8b
Engages in the research, development, production, and sale of surgical implants, instruments, and related products in the People’s Republic of China and internationally.
1858
HK$8.48
7D
-3.7%
1Y
-26.0%
Hygeia Healthcare Holdings
Market Cap: HK$5.4b
Offers oncology healthcare services in the People's Republic of China.
6078
HK$8.80
7D
0.2%
1Y
-41.5%
LEPU ScienTech Medical Technology (Shanghai)
Market Cap: HK$3.3b
An investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices.
2291
HK$11.31
7D
29.6%
1Y
-41.9%
Chaoju Eye Care Holdings
Market Cap: HK$1.7b
Owns and operates a network of ophthalmic hospitals and centers in the People’s Republic of China.
2219
HK$2.42
7D
-3.2%
1Y
-15.1%
Sisram Medical
Market Cap: HK$1.1b
Engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America.
1696
HK$2.26
7D
-5.0%
1Y
-48.0%
Yonghe Medical Group
Market Cap: HK$1.0b
Provides hair-related healthcare services in China.
2279
HK$2.02
7D
-2.4%
1Y
56.6%